Infant Bacterial Therapeutics AB (publ) has established a Nomination Committee for the AGM, which is planned to be held on May 4, 2022. The Nomination Committee is composed, according to descion by the AGM of 2021, of members appointed by the three large shareholders in terms of voting rights, wich all have accepted the invitation to join the committee. The following members were the large shareholders in terms of voting rights according to the shareholders register as of June 30, 2021, and they have appointed the following members: Annwall Rothschild Investments AB: Per-Erik Andersson, Six Sis AG: Sebastian Jahreskog, Fjarde AP-fonden: Jannis Kitsakis. The chairman of the Nomination Committee is Per-Erik Andersson since he is appointed by the large shareholder, in terms of voting rights, in IBT. The Committee's assignment is to present proposals to the AGM regarding; election of the Chairman of the AGM, election of Chairman and other members of the Board, election of Auditors as well as remuneration to the Board's members and auditor fees.